June 10, 2016
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
Tuesday, September 20, 2022
The University of Maryland School of Medicine (UMSOM) and the University of Maryland, Baltimore County (UMBC) were awarded a 5-year, $13.7 million grant from the National Institutes of Health (NIH) to enhance efforts at recruiting and training junior faculty from underrepresented groups in biomedical science. The grant comes from the NIH Common Fund, the Faculty Institutional Recruitment for Sustainable Transformation (FIRST) program, founded last year for the purpose of supporting efforts to hire diverse groups of early-career research faculty.
Thursday, March 24, 2022
UM School of Medicine Leads Research to Assess Meningococcal Vaccine for Infants and Young Children in Africa
Researchers at the University of Maryland School of Medicine (UMSOM)’s Center for Vaccine Development & Global Health (CVD) are leading a study to evaluate the use of a pentavalent – or five in one – meningococcal conjugate vaccine (NmCV-5) among infants and young children in the meningitis belt of sub-Saharan Africa. This is the final and pivotal study for World Health Organization (WHO) prequalification of this vaccine, which is the last stage to make the vaccine available for low- and middle-income countries.
Wednesday, January 27, 2021
Dr. Wilbur Chen, Nationally-Recognized Vaccine Researcher, Selected for Federal Committee that Guides Immunization Policies
Wilbur H. Chen, MD, MS, FIDSA, FACP, Professor of Medicine at the University of Maryland School of Medicine (UMSOM), has been named a new voting member of the federal government’s Advisory Committee on Immunization Practices (ACIP), the prestigious board of experts that makes recommendations on the safe use of vaccines for Americans. The U.S. Department of Health and Human Services selected Dr. Chen for the 15-member advisory committee based on his expertise and national leadership in vaccinology, infectious diseases, public health, and preventive medicine. He will remain in his current role at UMSOM while he serves in his four-year term, which began last month.
Thursday, January 09, 2020
UM School of Medicine Research Shows Less Severe Cases of Diarrheal Illness can Still Lead to Child Deaths, Even Weeks Following Onset of the Illness
Diarrheal diseases are a leading cause of death for young children, accounting for nine percent of all deaths worldwide in children under five years of age, with most occurring in children under two years of age. Now, researchers at the University of Maryland School of Medicine (UMSOM) found that even milder cases of diarrheal diseases can lead to death in young children.
Tuesday, December 10, 2019
UMSOM Researchers to Test Vaccine Designed to Protect Against Serious Illness from Contaminated Food and Water
Each year, millions of people contract serious diarrheal illnesses typically from contaminated food and water. Among the biggest causes of diarrheal diseases are the bacteria Shigella and enterotoxigenic Escherichia coli (ETEC), and researchers at the University of Maryland School of Medicine are testing a vaccine designed to offer protection against these serious pathogens.
Wednesday, October 30, 2019
UM School of Medicine's Myron M. Levine, MD, DTPH, to Receive Prestigious Lifetime Award for Five Decades of Pioneering Vaccine Research
Myron M. Levine, MD, DTPH, the Simon and Bessie Grollman Distinguished Professor at the University of Maryland School of Medicine (UMSOM), Associate Dean for Global Health, Vaccinology and Infectious Diseases, and Founder and Former Director of the Center for Vaccine Development and Global Health (CVD) is a co-recipient of the 2020 Research! America Geoffrey Beene Foundation Builders of Science Award for his pioneering vaccine and infectious disease research.
Monday, July 01, 2019
James B. Kaper, PhD, the James and Carolyn Frenkil Distinguished Dean’s Professor Vice Dean for Academic Affairs and Professor and Chairman of the Department of Microbiology & Immunology at the University of Maryland School of Medicine (UMSOM), received the 2019 American Society of Microbiology (ASM) D.C. White Award for his accomplishments in interdisciplinary research and mentoring in microbiology.
Wednesday, January 16, 2019
James B. Kaper, PhD, Professor and Chair of the Department of Microbiology & Immunology and Vice Dean for Academic Affairs, was invested as the James & Carolyn Frenkil Distinguished Dean’s Professor on January 10 before a packed audience at Westminster Hall. Surrounded by family, friends, past and present colleagues and distinguished scientists, Dr. Kaper joined the elite group of 82 SOM faculty who currently hold endowed professorships, the highest honor bestowed by the SOM on individual faculty members.
Thursday, December 20, 2018
Data collected from the Global Enteric Multicenter Study (GEMS), a multi-site research project studying diarrheal diseases that was designed and coordinated by researchers in the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM), are now available to scientists on two online data resources.
Friday, November 30, 2018
UM School of Medicine Announces Major Management Restructuring and Promotions, as Part of School-Wide Cultural Transformation Initiative
University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, announced today that, as part of a new school-wide “Program in Cultural Transformation,” the University of Maryland School of Medicine (UMSOM) will launch a major restructuring of its senior leadership positions to ensure that women are represented at the highest levels of the UMSOM.
Tuesday, July 31, 2018
University of Maryland School of Medicine Establishes Two Endowed Professorships Through Private Gifts and Matching State Funds
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that the school has been awarded matching funds from the Maryland E-Nnovation Initiative Fund (MEIF), administered by the Maryland Department of Commerce. The funds, when combined with private philanthropy, will enable UMSOM to establish two new endowed professorships – one in Microbiology and Immunology, and one in Pharmacology.
Tuesday, March 20, 2018
Vaccine experts at the University of Maryland School of Medicine (UMSOM) have begun multiple clinical trials of vaccines designed to protect against H7N9, an avian influenza virus that was first reported in humans in 2013 in China.
Friday, February 23, 2018
University of Maryland School of Medicine Vaccine Expert Highlights Need for Vaccination Among Older Adults During Capitol Hill Briefing
Today at a briefing on Capitol Hill, Wilbur Chen, MD, MS, Associate Professor of Medicine at the University of Maryland School of Medicine, warned that the U.S. population of adults 65 and older is expected to rise significantly over the next few decades, making vaccinations against diseases like influenza, pneumonia and shingles for this population very critical.
Monday, December 11, 2017
Each year there are more than three million cases of cholera worldwide, a disease transmitted through contaminated food and water that hits developing countries particularly hard. While the standard regimen for protecting against cholera with existing non-living oral cholera vaccines includes administering two doses over a two-week period, research at the University of Maryland School of Medicine (UMSOM) now shows that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks more quickly.
Wednesday, October 11, 2017
Wilbur Chen, MD, MS, Associate Professor of Medicine at the University of Maryland School of Medicine (UM SOM), was elected as a Fellow by the Board of Directors of the Infectious Disease Society of America (IDSA). Fellowship in IDSA is a top honor for those who have achieved professional excellence and have provided significant service as an infectious disease physician and scientist.
Thursday, August 03, 2017
The University of Maryland School of Medicine (UM SOM) has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal disease in young children in developing countries and a common cause of “traveler’s diarrhea” among travelers to these countries.
Thursday, June 08, 2017
University of Maryland School of Medicine Vaccine Researcher Receives Top Award in the Study of Infectious Diseases from National Foundation
Myron M. Levine, MD, DTPH, the Simon and Bessie Grollman Distinguished Professor and Associate Dean for Global Health, Vaccinology and Infectious Disease at UM SOM, has been awarded the Maxwell Finland Award for Scientific Achievement by the National Foundation for Infectious Diseases (NFID).
Monday, May 15, 2017
A cholera vaccine developed by scientists at the University of Maryland School of Medicine’s Center for Vaccine Development (CVD) has been recommended by the U.S. Centers for Disease Control and Prevention (CDC) for use as a protection for U.S. adults traveling to areas with cholera. The CDC’s latest recommendation was published on May 11, in Morbidity and Mortality Weekly Report.
Monday, May 15, 2017
Myron M. Levine, MD, DTPH, the Simon and Bessie Grollman Distinguished Professor and Associate Dean for Global Health, Vaccinology and Infectious Disease at UM SOM, has been awarded the Maxwell Finland Award for Scientific Achievement by the National Foundation for Infectious Diseases (NFID). The award honors his extensive accomplishments in public health; over his career, he has identified solutions to major sources of disease in the developing world, including cholera, typhoid, and Shigella dysentery. The award will be presented on Thursday, May 18, 2017 at the Hyatt Regency Bethesda in Bethesda, Md.
Tuesday, January 17, 2017
Special Issue of Pathogens and Disease Highlights Innovative Research by Scientists at the University of Maryland School of Medicine in Collaboration with UM School of Dentistry
New research by scientists at the University of Maryland School of Medicine (UM SOM) and the University of Maryland School of Dentistry (UM SOD), is highlighted in a special issue of Pathogens and Disease.
Friday, December 23, 2016
An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine (UM SOM).
Tuesday, October 04, 2016
UM SOM Launches Unprecedented Initiatives to Create New Generation of Research Scientists Among Students, Trainees and Faculty
New and expanded research development programs at the University of Maryland School of Medicine will include focus on developing junior, minority and female faculty investigators as well as students and trainees.